Skip to main content

Table 4 Serum iron studies at different time points in the study

From: Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial

S.Iron (μg/dL)

Baseline

28.5 (14–78)

32 (14–74.1)

0.15

 3 weeks

178 (49.7–345)

187 (40–628.9)

0.30

 6 weeks

156 (72–250)

152 (71.6–561.6)

0.78

 12 weeks

112 (72–187)

107.5 (65–327)

0.60

S. Ferritin (μg/L)

 Baseline

7.9 (0.4–22.3)

9 (0.94–23)

0.46

 3 weeks

343 (25.7–843)

298 (13–771)

0.02

 6 weeks

291.5 (123–643)

233.3 (54.5–645)

0.44

 12 weeks

187.5 (69–443)

145.5 (40–382)

0.13

Transferrin saturation (%)

 Baseline

8 (0.4–30.5)

12.5 (0.03–19.1)

0.035

 3 weeks

35.85 (12.2–64)

39.81 (14–138.4)

0.50

 6 weeks

37.65 (13.6–53)

37 (16.82–84.5)

0.84

12 weeks

32.7 (5–46)

34.5 (19.6–65.7)

0.53

TIBC (μg/dL)

 Baseline

493.8 ± 106.5

530.0 ± 96.0

0.07

 3 weeks

413.4 ± 76.9

439.9 ± 86.0

0.10

 6 weeks

348.4 ± 72.4

354.9 ± 88.4

0.68

 12 weeks

284.7 ± 50.9

290.2 ± 60.7

0.62

  1. Data expressed as mean ± SD/median (min-max)